Literature DB >> 12774221

Transient proximal tubular renal injury following Ecstasy ingestion.

Charles Kwon1, Arno Zaritsky, Vikas R Dharnidharka.   

Abstract

Multiple renal adverse effects have been anecdotally reported with the ingestion of 3,4-methylenedioxymethamphetamine (Ecstasy), a widely used recreational drug. These side effects include acute renal failure, necrotizing vasculitis, and hyponatremia, the mechanisms for which are unknown. We report a case of transient acute proximal tubular injury and hyponatremia associated with Ecstasy use. An 18-year-old woman presented with new onset seizures and polydipsia. Her initial laboratory evaluation revealed hyponatremia (Na 117 mEq/L), polyuria (urine output >400 mL/h for several hours), renal glycosuria (blood glucose 120 mg/dL, urine glucose >1,000 mg/dL), and solute diuresis (urine osmolality 552 mOsm/kg H2O). Urine electrolyte values reflected a low tubular reabsorption of phosphorus (TRP) of 68.1% (expected TRP >85% at serum P 2.3 mg/dL) with an appropriate transtubular potassium gradient of 3.0 (serum K 3.7 mEq/L). Her hyponatremia was slowly corrected. A repeat TRP after 48 h had normalized to 86.5%, and her glycosuria resolved. An extensive toxin screen was later reported positive for Ecstasy. To our knowledge, this is the first example of an acute and transient proximal tubular injury with Ecstasy ingestion. This complication may become more apparent with increasing use of this drug.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12774221     DOI: 10.1007/s00467-003-1164-7

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  12 in total

1.  Acute renal failure after ecstasy.

Authors:  I H Fahal; D F Sallomi; M Yaqoob; G M Bell
Journal:  BMJ       Date:  1992-07-04

2.  Hyperpyrexia and rhabdomyolysis after MDMA ("ecstasy") abuse.

Authors:  G R Screaton; M Singer; H S Cairns; A Thrasher; M Sarner; S L Cohen
Journal:  Lancet       Date:  1992-03-14       Impact factor: 79.321

3.  Increasing MDMA use among college students: results of a national survey.

Authors:  Jared Strote; Jae Eun Lee; Henry Wechsler
Journal:  J Adolesc Health       Date:  2002-01       Impact factor: 5.012

4.  Severe hyponatremia and inappropriate antidiuretic hormone secretion following ecstasy use.

Authors:  I Ajaelo; K Koenig; E Snoey
Journal:  Acad Emerg Med       Date:  1998-08       Impact factor: 3.451

5.  Necrotizing renal vasculopathy resulting in chronic renal failure after ingestion of methamphetamine and 3,4-methylenedioxymethamphetamine ('ecstasy')

Authors:  C Bingham; M Beaman; A J Nicholls; P P Anthony
Journal:  Nephrol Dial Transplant       Date:  1998-10       Impact factor: 5.992

6.  Hyponatraemia and death after "ecstasy" ingestion.

Authors:  M J Parr; H M Low; P Botterill
Journal:  Med J Aust       Date:  1997-02-03       Impact factor: 7.738

7.  Acute renal failure due to accelerated hypertension following ingestion of 3,4-methylenedioxymethamphetamine ('ecstasy').

Authors:  G Woodrow; P Harnden; J H Turney
Journal:  Nephrol Dial Transplant       Date:  1995       Impact factor: 5.992

8.  Increasing use of "Ecstasy" (MDMA) and other hallucinogens on a college campus.

Authors:  M J Cuomo; P G Dyment; V M Gammino
Journal:  J Am Coll Health       Date:  1994-05

9.  Ecstasy-induced toxicity in rat liver.

Authors:  G Beitia; A Cobreros; L Sainz; E Cenarruzabeitia
Journal:  Liver       Date:  2000-02

10.  Amphetamine-induced acute renal failure.

Authors:  R J Foley; K Kapatkin; R Verani; E J Weinman
Journal:  South Med J       Date:  1984-02       Impact factor: 0.954

View more
  7 in total

Review 1.  A review of basic to clinical studies of the association between hyperammonemia, methamphetamine.

Authors:  Marzieh Jafari Fakharbad; Mohammad Moshiri; Mohammad Mehdi Ommati; Mehdi Talebi; Leila Etemad
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-05-23       Impact factor: 3.195

Review 2.  Nephrotoxic effects of common and emerging drugs of abuse.

Authors:  William F Pendergraft; Leal C Herlitz; Denyse Thornley-Brown; Mitchell Rosner; John L Niles
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-17       Impact factor: 8.237

Review 3.  Non-drug-induced nephrotoxicity.

Authors:  Justine Bacchetta; Laurence Dubourg; Laurent Juillard; Pierre Cochat
Journal:  Pediatr Nephrol       Date:  2009-04-28       Impact factor: 3.714

Review 4.  Nephrotoxic effects of designer drugs: synthetic is not better!

Authors:  Randy L Luciano; Mark A Perazella
Journal:  Nat Rev Nephrol       Date:  2014-03-25       Impact factor: 28.314

Review 5.  Ecstasy (MDMA) and its effects on kidneys and their treatment: a review.

Authors:  Feyza Bora; Fatih Yılmaz; Taner Bora
Journal:  Iran J Basic Med Sci       Date:  2016-11       Impact factor: 2.699

Review 6.  Systematic review of nephrotoxicity of drugs of abuse, 2005-2016.

Authors:  Kanaan Mansoor; Murad Kheetan; Saba Shahnawaz; Anna P Shapiro; Eva Patton-Tackett; Larry Dial; Gary Rankin; Prasanna Santhanam; Antonios H Tzamaloukas; Tibor Nadasdy; Joseph I Shapiro; Zeid J Khitan
Journal:  BMC Nephrol       Date:  2017-12-29       Impact factor: 2.388

7.  Ecstasy induces reactive oxygen species, kidney water absorption and rhabdomyolysis in normal rats. Effect of N-acetylcysteine and Allopurinol in oxidative stress and muscle fiber damage.

Authors:  Ana C de Bragança; Regina L M Moreau; Thales de Brito; Maria H M Shimizu; Daniele Canale; Denise A de Jesus; Ana M G Silva; Pedro H Gois; Antonio C Seguro; Antonio J Magaldi
Journal:  PLoS One       Date:  2017-07-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.